<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: farber cancer institute</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'farber cancer institute'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22farber+cancer+institute%22&t=%22farber+cancer+institute%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:54:22 +0100</lastBuildDate>
        <item>
            <title>Realistic Medicine: The Kind Of Thinking To Look For</title>
            <link>http://www.medworm.com/index.php?rid=4382762&amp;cid=t_287629_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Frealistic-medicine-the-kind-of-thinking-to-look-for%2F2011.01.21</link>
            <description>There are several stages in becoming an empowered, engaged, activated patient &amp;#8212; a capable, responsible partner in getting good care for yourself, your family, whoever you’re caring for. One ingredient is to know what to expect, so you can tell when things seem right and when they don’t.
Researching a project today, I came across an article* published in 2006: &amp;#8221;Key Learning from the Dana-Farber Cancer Institute’s 10-Year Patient Safety Journey.&amp;#8221; This table shows the attitude you’ll find in an organization that has realized the challenges of medicine and is dealing with them realistically:

“Errors are everywhere.” “Great care in a high-risk environment.” What kind of attitude is that? It’s accurate.
This work began after the death of Boston Globe healt...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4382762</comments>
            <pubDate>Fri, 21 Jan 2011 22:00:29 +0100</pubDate>
            <guid isPermaLink="false">4382762</guid>        </item>
        <item>
            <title>Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=4349659&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F01%2F14%2Fcaris-life-sciences-launches-molecular-profiling-service-for-ovarian-cancer-patients%2F</link>
            <description>Caris Life Sciences announces the launch of a new molecular profiling service for ovarian cancer patients Caris Life Sciences, Inc. (Caris), a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, announced the launch of a new, Caris Target Now™ molecular profile [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4349659</comments>
            <pubDate>Fri, 14 Jan 2011 22:11:53 +0100</pubDate>
            <guid isPermaLink="false">4349659</guid>        </item>
        <item>
            <title>Dana-Farber Researchers “OncoMap” The Way To Personalized Treatment For Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4175920&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F11%2F16%2Fdana-farber-researchers-oncomap-the-way-to-personalized-treatment-for-ovarian-cancer%2F</link>
            <description>Researchers have shown that point mutations – mis-spellings in a single letter of genetic code – that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalized medicine in which every patient could have their tumor screened, [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4175920</comments>
            <pubDate>Wed, 17 Nov 2010 07:24:47 +0100</pubDate>
            <guid isPermaLink="false">4175920</guid>        </item>
        <item>
            <title>Girls with Stage I Ovarian Germ-Cell Tumors Can Safely Skip Chemotherapy Until Recurrence</title>
            <link>http://www.medworm.com/index.php?rid=4122024&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F10%2F31%2Fgirls-with-stage-i-ovarian-germ-cell-tumors-can-safely-skip-chemotherapy-until-recurrence%2F</link>
            <description>Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center found that as many as 50 percent of young girls treated for germ-cell ovarian tumors may be safely spared chemotherapy using a &amp;#8220;watch and wait&amp;#8221; strategy to determine whether follow-up treatment is needed. Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center (DF/CHCC) found that as many as 50 percent of young girls [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4122024</comments>
            <pubDate>Sun, 31 Oct 2010 22:23:31 +0100</pubDate>
            <guid isPermaLink="false">4122024</guid>        </item>
        <item>
            <title>Novartis, Dana-Farber, An Angry Exec And Money</title>
            <link>http://www.medworm.com/index.php?rid=4119713&amp;cid=t_287629_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fiqx9Ideosb4%2F</link>
            <description>There&amp;#8217;s nothing like a nasty battle over the rights to a drug under development to make for interesting reading. And so we present you with some intense legal haggling over a molecule known as WZ4002, which was discovered by researchers at the Dana-Farber Cancer Institute in Boston for combating non small-cell lung cancer with specific gene mutations. The compound is potentially quite valuable because it may be able to treat patients who don&amp;#8217;t respond to existing cancer pills.
The dispute, however, is not your run-of-the-mill spat over development rights. Instead, the lawsuit peels back the curtain on some of the jockeying that occurs among universities, drugmakers and scientists when potentially lucrative intellectual property rights are in play. Here&amp;#8217;s why: the legal ba...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4119713</comments>
            <pubDate>Fri, 29 Oct 2010 14:35:42 +0100</pubDate>
            <guid isPermaLink="false">4119713</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3999295&amp;cid=t_287629_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FTCrv077MheI%2F</link>
            <description>And so the end of another work week is near. Which means the time has come to plan your weekend activities. Anything special in the offing? How about picking apples? Or a walk in the park? We plan to watch one of the short people on the football field and catch up on some reading. Meanwhile, another day awaits. So here are a few items to help you along. And whatever you do this weekend, have a great time&amp;#8230;
Amgen And J&amp;#038;J Recall Some Anemia Meds (Reuters)
EMA Rejects Merck KGaA&amp;#8217;s MS Pill (Bloomberg News)
Alnylam To Cut Up To 30 Percent Of Workforce (Associated Press)
Sanofi-Aventis Signs Deal With Dana Farber Cancer Institute (PharmaTimes)
Glaxo&amp;#8217;s Advair Follow-Up Shows Promise In Tests (Reuters)
Xanodyne Pharma Plans Staff Cuts (The Cincinnati Enquirer)
EU Finds No Lin...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3999295</comments>
            <pubDate>Fri, 24 Sep 2010 11:53:50 +0100</pubDate>
            <guid isPermaLink="false">3999295</guid>        </item>
        <item>
            <title>2010-2011 U.S. News &amp; World Report “Best Hospitals” List</title>
            <link>http://www.medworm.com/index.php?rid=3758063&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F07%2F15%2F2010-2011-u-s-news-world-report-best-hospitals-list%2F</link>
            <description>This week, U.S. News &amp;#38; World Report issued its 2010-2011 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment, and Johns Hopkins is rated #1 in gynecology and #1 overall based upon all medical specialties. If you would like more information regarding [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3758063</comments>
            <pubDate>Thu, 15 Jul 2010 20:16:29 +0100</pubDate>
            <guid isPermaLink="false">3758063</guid>        </item>
        <item>
            <title>2009-2010 U.S. News &amp; World Report Best U.S. Hospital Rankings</title>
            <link>http://www.medworm.com/index.php?rid=2611148&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F07%2F16%2F2009-2010-u-s-news-world-report-best-u-s-hospital-rankings%2F</link>
            <description>Today, U.S. News &amp;#38; World Report issued its 2009-2010 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment; Brigham and Women&amp;#8217;s Hospital is rated #1 in gynecology; and Johns Hopkins is rated #1 overall based upon all medical specialties.
If you would like [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2611148</comments>
            <pubDate>Fri, 17 Jul 2009 00:14:29 +0100</pubDate>
            <guid isPermaLink="false">2611148</guid>        </item>
        <item>
            <title>Genetic Testing For Hereditary Breast and Ovarian Cancers Greatly Underutilized By High-Risk Women</title>
            <link>http://www.medworm.com/index.php?rid=2442555&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F05%2F24%2Fgenetic-testing-for-hereditary-breast-and-ovarian-cancers-greatly-underutilized-by-high-risk-women%2F</link>
            <description>A women&amp;#8217;s lifetime breast cancer risk is approximately 13 percent, and her ovarian cancer risk is less than 2 percent.  But women with BRCA1 (BReast CAncer 1) or BRCA2 (BReast CAncer 2) gene mutations may be 3 to 7 times more likely to develop breast cancer, and 9 to 30 times more likely to develop [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2442555</comments>
            <pubDate>Mon, 25 May 2009 01:03:00 +0100</pubDate>
            <guid isPermaLink="false">2442555</guid>        </item>
        <item>
            <title>Patty Franchi Flaherty Loses Battle to Ovarian Cancer, But Deserves a Long Standing Ovation</title>
            <link>http://www.medworm.com/index.php?rid=1727797&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F08%2F19%2Fpatty-franchi-flaherty-loses-battle-to-ovarian-cancer-but-deserves-a-long-standing-ovation%2F</link>
            <description>It is with deep regret that I must inform you that, Patty Franchi Flaherty, founder of the nonprofit organization Ovations for the Cure of Ovarian Cancer, peacefully succumbed to her nine-year battle with the disease on August 18, 2008, surrounded by friends and family. She was 53 years old. Patty was a legendary ovarian cancer [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727797</comments>
            <pubDate>Tue, 19 Aug 2008 19:34:58 +0100</pubDate>
            <guid isPermaLink="false">1727797</guid>        </item>
        <item>
            <title>The Emerging Field of Oncofertility</title>
            <link>http://www.medworm.com/index.php?rid=1727803&amp;cid=t_287629_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F29%2Fthe-emerging-field-of-oncofertility%2F</link>
            <description>&amp;#8220;Welcome to the burgeoning world of oncofertility. As cancer survival rates climb and patients focus on quality-of-life issues, especially fertility, Dauer and others like her are forcing two very different medical specialties-oncology and assisted reproduction-to come together. ‘The narrative of cancer is no longer that it&amp;#8217;s a death sentence; it&amp;#8217;s a bump in your [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727803</comments>
            <pubDate>Tue, 29 Jul 2008 18:35:49 +0100</pubDate>
            <guid isPermaLink="false">1727803</guid>        </item>
    </channel>
</rss>

